Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

Delayed Quote. Delayed  - 08/24 05:19:39 pm
2.91 CHF   +0.34%
07/27 ADDEX THERAPEUT : ADX71441 Demonstrates Positive Results in Highly T..
07/20 ADDEX THERAPEUT : LifeSci Capital Issues Equity Research Report on A..
06/24 ADDEX THERAPEUT : Annual General Meeting Scheduled for 23 June 2016
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
08/18/2016 08/19/2016 08/22/2016 08/23/2016 08/24/2016 Date
2.75(c) 2.73(c) 2.76(c) 2.9(c) 2.91 Last
18 429 5 501 39 399 87 622 159 890 Volume
-1.79% -0.73% +1.10% +5.07% +0.34% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company was founded by Vincent Mutel, Timothy Dyer and Mark Epping-Jordan in May 2002 and is headquartered in Geneva, Switzerland. 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
07/27 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Highly Translatio..
07/20 ADDEX THERAPEUTICS : LifeSci Capital Issues Equity Research Report on Addex Ther..
07/19 ADDEX THERAPEUTICS LTD : LifeSci Capital Initiates Coverage of Addex Therapeutic..
06/24 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
06/24 ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at 2016 Annual Ge..
06/13 ADDEX THERAPEUTICS : mGluR4 and mGluR7 Programs Demonstrate Potential in Preclin..
06/09 ADDEX THERAPEUTICS : ADX71441 Demonstrates Positive Results in Non-Human Primate..
06/08 ADDEX THERAPEUTICS : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics
06/02 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
06/02 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 23 June 2016
More news
Sector news : Biotechnology & Medical Research - NEC
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 4th Update
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Managers
NameTitle
Timothy Dyer Chief Executive Officer
Vincent M. Lawton Chairman
Sonia Maria Poli Chief Scientific Officer
Raymond George Hill Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD-4.21%40
INCYTE CORPORATION-24.48%15 397
CELLTRION, INC.--.--%11 401
LONZA GROUP AG14.78%10 369
QUINTILES TRANSNATIONA..10.70%9 006
ALKERMES PLC-41.42%7 047
More Results